The record
| Class | hormone |
|---|---|
| Also known as | Pitocin, Syntocinon, Love hormone, Trust hormone |
| Chain length | - |
| Molecular weight | 1,007.2 Da |
| Half-life | 3-9 minutes |
| Route | SC (injectable), IV/IM (obstetric), Intranasal (behavioral) |
| Studied for | Labor induction, Labor augmentation, Postpartum hemorrhage prevention/treatment, Incomplete abortion (FDA approved) |
| Research use | Autism spectrum disorder, Social anxiety, Depression, PTSD, Weight management |
| What has been shown | Induces uterine contractions; Prevents postpartum hemorrhage; Enhances social cognition (intranasal); Reduces anxiety in social situations |
| How it works | Nonapeptide neurohormone that binds oxytocin receptors (OXTR), activating Gq/11 signaling. In the CNS, modulates social behavior, trust, and bonding. Peripherally, causes uterine contractions and milk ejection. Acts as neuromodulator affecting dopamine, serotonin, and GABA systems. |
| Patent status | Generic |
| Regulatory status | FDA approved (Pitocin) for obstetric use |
Blank = not established in the record. Nothing is estimated to fill a gap.
Where it is matched
- Stress Modulation / Calm State (affection, 70%)
- Mood Stability Environment (affection, 39%)
- adaptation disorders (illness, 30%)
- anxiety disorders / anxiety states (illness, 30%)
- astheno-neurotic states (illness, 30%)
- FDA-approved for hypoactive sexual desire disorder in premenopausal women (illness, 30%)
- Incomplete abortion (illness, 100%)
- Labor augmentation (illness, 100%)
- Labor induction (illness, 100%)
- Postpartum hemorrhage prevention/treatment (illness, 100%)
- Anxiety or stress (symptom, 67%)